IGFBP3 and Decreased liver function: The described KH patient with a heterozygous NEK11 mutation showed glucagon unresponsive hypoglycemia, migraine, cognitive disability, motor impairments, mild hepatopathy, and decreased plasma IGFBP3 (71, 87).